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Pluripotency is a unique biological state that allows
cells to differentiate into any tissue type. Here we
describe a candidate pluripotency factor, Ronin,
that possesses a THAP domain, which is associated
with sequence-specific DNA binding and epigenetic
silencing of gene expression. Ronin is expressed pri-
marily during the earliest stages of murine embryonic
development, and its deficiency in mice produces
periimplantational lethality and defects in the inner
cell mass. Conditional knockout of Ronin prevents
the growth of ES cells while forced expression of
Ronin allows ES cells to proliferate without differenti-
ation under conditions that normally do not promote
self-renewal. Ectopic expression also partly com-
pensates for the effects of Oct4 knockdown. We
demonstrate that Ronin binds directly to HCF-1,
a key transcriptional regulator. Our findings identify
Ronin as an essential factor underlying embryogene-
sis and ES cell pluripotency. Its association with
HCF-1 suggests an epigenetic mechanism of gene
repression in pluripotent cells.
INTRODUCTION
Pluripotency, a biological state restricted to certain embryonic
cells, enables development into any cell type in the body (Peder-
sen, 1986). Because this property can be exploited for genetic
engineering and holds great promise for applications in regener-
ative medicine, an important goal is to understand the molecular
pathways unique to pluripotent cells. Embryonic stem (ES) cells,
derived from the inner cell mass (ICM) of blastocysts, are the
most commonly used cell type in studies of early embryonic de-
velopment and the pluripotent state (Evans and Kaufman, 1981;
Martin, 1981; Thomson et al., 1998), largely because of their abil-1162 Cell 133, 1162–1174, June 27, 2008 ª2008 Elsevier Inc.ity to self-renew in tissue culture for extended periods without
differentiation.
Despite recent progress in reprogramming somatic cells to
an embryonic-like state (so-called induced pluripotent stem, or
iPS, cells) by manipulation of several key transcription factors
(Takahashi and Yamanaka, 2006; Maherali et al., 2007; Okita
et al., 2007; Takahashi et al., 2007; Wernig et al., 2007; Yu
et al., 2007), the precise molecular mechanisms that underlie
pluripotency remain elusive. It is proposed that a tightly balanced
core set of specific transcription factors, able to promote self-
renewal by repressing transcription factors that initiate differen-
tiation programs, are the major driving forces in ES cell mainte-
nance (Bernstein et al., 2006; Boyer et al., 2005, 2006; Lee
et al., 2006). A second tier of control is likely achieved via
enzyme-mediated modifications of chromatin (e.g., histone
acetylation and methylation at specific residues and chromatin
remodeling) that may ‘‘prime’’ critical differentiation genes for
subsequent transcription (Boyer et al., 2006; Houlard et al.,
2006; Klochendler-Yeivin et al., 2000). Whether the epigenetic
status of ES cells directly reflects the actions of transcription
factors known to be involved in pluripotency, or perhaps those
yet to be linked to the pluripotent state, remains unclear.
Oct4, Sox2, and Nanog are considered part of the core set of
pluripotency factors (Avilion et al., 2003; Chambers et al., 2003;
Nichols et al., 1998). Although each of these proteins has been
described as a ‘‘master regulator’’ of pluripotency, only Oct4
appears absolutely essential, while both Sox2 and Nanog ap-
pear dispensable, at least in certain molecular contexts (Masui
et al., 2007; Chambers et al., 2007). Contributing to the complex-
ity of ES cell regulation is the observation that ectopic expression
of Nanog, but notOct4 and Sox2, will sustain self-renewal under
unfavorable conditions but does not override the differentiation
effects of forced downregulation of either Oct4 or Sox2 (Cham-
bers et al., 2003;Matsui et al., 1992; Niwa et al., 2000).Moreover,
the exact manner in which particular epigenetic modifiers, such
as histone-modifying enzymes, influence the state of pluripo-
tency and engage in crosstalk with other pluripotency factors
is unclear.
We previously showed that certain components of the cell
death system, Caspase-3 in particular, specifically cleave and
deplete Nanog protein, compelling ES cells to exit their self-
renewal phase and induce differentiation (Fujita et al., 2008).
This discovery led us to hypothesize that Caspase-3 might rec-
ognize other pluripotency factors critical for ES cell function
and to devise a yeast two-hybrid screen for Caspase-3 targets
in ES cells that would fill this role. Here we describe a nuclear
protein targeted by Caspase-3 that is expressed during the ear-
liest stages of embryonic development, is essential for the main-
tenance of pluripotent stem cells both in vitro and in vivo, allows
ES cells to self-renew under conditions that normally suppress
self-renewal, and partly compensates for Oct4 knockdown in
ES cells. Designated Ronin (a masterless Japanese samurai)
because of its lack of any apparent relationship to known ‘‘mas-
ter’’ regulators of pluripotency, this factor contains a zinc-finger
DNA-binding motif (THAP domain) common to many proteins
associated with chromatin modification and silencing of gene
expression (Roussigne et al., 2003a, 2003b; Macfarlan et al.,
2005). Ronin binds directly to the host cell factor 1 (HCF-1) pro-
tein, a key regulator of transcriptional control that is associated
with protein complexes involved in histone modification, sug-
gesting that it acts through a previously unrecognized pathway
of pluripotency control.
RESULTS
Identification of Ronin by Yeast Two-Hybrid Screening
Previous studies by our group showed that Nanog is targeted
and cleaved by the proapoptotic enzyme Caspase-3 upon in-
duction of ES cell differentiation (Fujita et al., 2008), leading us
to hypothesize that other, still unknown factors critical for ES
cell pluripotency may be Caspase-3 targets as well. We there-
fore performed yeast two-hybrid screening of a human ES cell
cDNA expression library, using constitutively active Caspase-3
(mCasp3rev) as bait. mCasp3rev spontaneously folds into its
active conformation and recognizes and binds to target proteins
but no longer cleaves them owing to a C163S substitution. An
estimated 32million clones were screened, with 556 clones test-
ing positive for interaction with the Caspase-3 mutant. Further
study of a representative set of 286 clones, using rescued plas-
mids, digestion with restriction enzymes, and a validation assay,
yielded 116 candidate genes. Subsequent sequencing and anal-
ysis with an in vitro transcription/translation Caspase-3 cleavage
assay identified a cDNA whose protein product contained ele-
ments of a DNA-binding factor with striking similarities to the
DNA-binding domain of the Drosophila P element transposase.
This protein, termed Ronin for reasons given in the Introduction,
proved to be an authentic target of Caspase-3 in further analyses
(Figure S1A available online).
Characterization of the orthologous 305 residue Ronin protein
encoded by the mouse cDNA (predicted length, 1809 bases)
revealed a THAP domain at the N terminus (Figure 1A), which
comprises a zinc-finger DNA-binding motif defined, in part, by
a C2CH signature (Cys-Xaa2-4-Cys-Xaa33-50-Cys-X-aa2). There
are also two polyalanine motifs, a polyglutamine tract (22 Qs),
and a predicted coiled-coil structural domain at the C terminus.
A nuclear translocation signal (NLS) is located toward the C ter-
minus. A search for Ronin orthologs across multiple animal spe-
cies showed exceptional conservation of the N and C termini,
even among more distant species (e.g., humans versus zebra-
fish, Figures S1B and S1C). The most closely related nonverte-
brate protein with a similar THAP domain is a transposase in
the sea urchin (43% identity, seq XP_790851.2), which is related
to several Drosophila transposases, including the P element
transposase and the THAP domain-containing protein THAP9
in humans and other primates.
To determine the DNA sequence recognized by Ronin, we
used the SELEX procedure (Bouvet, 2000) with a mouse
Ronin-His/V5 recombinant protein (see Experimental Proce-
dures for details) to select random oligonucleotides for sequenc-
ing. We identified a consensus sequence (Figure 1B, top panel)
as well as a specific sequence (3x) that was represented three
times in the sequenced pool. Gel-mobility shift experiments con-
firmed that the 3x sequence is readily bound by Ronin (Figure 1B,
bottom panel). Other related oligonucleotides were not able to
abolish the gel shift, indicating that Ronin does not bind nonspe-
cifically to either DNA or DNA ends (see Figure S1D). These data
show that Ronin, like other proteins with a THAP domain, is a nu-
clear protein, as confirmed by immunofluorescence (see below),
and binds to DNA in a sequence-specificmanner. The coiled-coil
motif at the C terminus may represent a second functional
domain, as indicated by its capacity to bind directly to the
HCF-1 protein (see below).
Ronin Expression Patterns
Northern blot analysis of multiple tissues in the mouse failed to
detect appreciable expression of the Ronin gene, except in the
mouse ES cell line used as a positive control (Figure 1C). To fur-
ther clarify the expression patterns of Ronin, we generated a lacZ
transgenic reporter mouse line in which a 3.3 kb genomic frag-
ment representing the mouse Ronin promoter was ligated into
the open reading frame of the b-galactosidase gene. The resul-
tant mouse line expressed b-galactosidase in tissues where
the Ronin promoter was active, in a pattern similar to the expres-
sion of wild-type (WT) Ronin. As in the Northern blot analysis,
Ronin was not abundantly expressed in adult tissues, with two
exceptions: (1) ovary, which showed very strong positive staining
in oocytes (Figure 1D, left) and (2) some areas of the brain,
including hippocampus, olfactory bulb, and Purkinje cells
(Figure 1D, right). To establish the subcellular compartment in
which Ronin is found, we raised an antibody against Ronin
(Figure S2A). Immunostaining with this antibody in adult ovaries
showed localization of Ronin mainly in the ooplasm without any
evidence of its presence in the nucleus (Figure 1E, left). This
pattern of staining contrasted with the detection of Ronin
throughout the zygote (Figure 1E, right).
Using the lacZ animal model to assess Ronin expression dur-
ing early embryonic development, we found that lacZ activity first
appears at the 2-cell stage, intensifies during the 8-cell and com-
pact morula stages, but subsides in the blastocyst (Figure 1F).
However, immunofluorescence staining revealed that Ronin pro-
tein was still present at the blastocyst stage (Figure 1G), indicat-
ing that the lacZ reporter system is not as sensitive as antibody
staining and therefore could underestimate Ronin transcription
by comparison with the results of RT-PCR or microarray
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Figure 1. Ronin Is a Nuclear THAP Domain Protein Whose Expression Is Restricted to Early Embryonic Cells and Undifferentiated ES Cells
(A) Schematic diagram of the Ronin protein showing a THAP domain at the N terminus. NLS, nuclear translocation signal; polyQ, polyglutamine tract; polyA, poly-
alanine sequence; THAP, Thanatos-associated protein; aa, amino acid.
(B) SELEX identification of the consensus sequence recognized by Ronin DNA-binding motif (top) and gel-shift experiments with a specific DNA sequence (bot-
tom). A motif search identified a specific consensus (top) and a ‘‘3x sequence.’’ Binding of Ronin-Flag to the biotinylated 3x sequence was verified by gel-shift
experiments that could be inhibited by the Flag antibody and either double-stranded or single-stranded unlabeled competitor 3x molecules. Triangles indicate
gel-shift complexes.
(C) Northern Blot analysis of multiple mouse tissues.
(D) X-Gal staining of tissues isolated from mpRonin-lacZ reporter mice.
(E) Immunostaining of oocytes and zygotes isolated from adult females with a Ronin antiserum. (bar = 10 mm).
(F) Ronin promoter-driven lacZ expression during embryo development.
(G) Immunostaining of Ronin in morula and blastocyst-stage embryos and in in vitro inner cell mass (ICM) outgrowth.
(H) Confocal images of mouse ES cells stained with Ronin antibody.
(I) lacZ expression in undifferentiated ES cells, in the absence ofMEFs and LIF or after EB formation for 3 days (scale bars: D left 30 mm,D right 80 mm, E left 30 mm,
E right 20 mm).
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analysis. Although present in both the cytoplasm and the nucleus
of blastomeres in morula-stage embryos, Ronin appeared
mainly in the cytoplasm of cells within the blastocysts, suggest-
ing that its function may be regulated by shuttling of the protein
between the cytoplasm and nucleus, similar to its fate at the
oocyte/zygote transition. Once the blastocysts were placed in
culture, the Ronin protein was again mostly localized in the
nucleus with only scant amounts detected in the cytoplasm
(Figure 1G).
Immunostaining for Ronin protein was strongly positive in the
nucleus of undifferentiated mouse and human ES cells and was
distributed in an uneven pattern that primarily exluded DAPI-
positive areas, suggesting that Ronin is an abundant nuclear
protein associated with open chromatin (Figures 1H and S2B).
These results led us to study reporter gene activity in ES cells
isolated from transgenic blastocysts to determine the temporal
pattern of Ronin expression upon induction of differentiation.
lacZ activity was detected in undifferentiated ES cells grown in
the presence of amouse embryonic fibroblast (MEF) feeder layer
(Figure 1I, left). When these cultures were transferred to gelatin-
coated dishes and maintained in the absence of leukemia inhib-
itory factor (LIF) andMEFs or incubated as hanging drops to form
embryoid bodies (EB), lacZ activity was virtually undetectable in
the differentiated cells (Figure 1I, middle and right). Overall, these
findings indicate that Ronin expression is mainly restricted to
pluripotent cells of the developing embryo, to oocytes, and to
certain regions of the adult brain.
Ronin Knockout Leads to Periimplantational Lethality
To test whether Ronin plays a critical role in early embryonic de-
velopment, we knocked out a single allele of the gene in mouse
ES cells, generating Ronin+/ mice (see Experimental Proce-
dures). When Ronin+/ male and female littermates were
crossed, none of the 98 offspring at weaning age were
Ronin/, demontrating that a Ronin null genotype is embryoni-
cally lethal. An estimated two-thirds of the offspring (67 animals)
were Ronin+/ and one-third (31 animals) were Ronin+/+, sup-
porting a lethal phenotype. To determine the embryonic stage
of lethality, we crossedRonin+/ animals and dissected and gen-
otyped embryos at E7.5. Of the 26 decidua examined, 7 (27%)
were empty, 8 (31%) contained embryos that were Ronin+/+,
and 11 (42%) contained embryos that were Ronin+/. Empty
swollen decidua were similar in size to those containing em-
bryos, an indication that implantation and decidualization had
proceeded normally (Figure 2A, left). Crossing Ronin+/ females
with Ronin+/+ males did not yield empty decidua. Approximately
half of the resultant embryos were Ronin+/, while the other half
were Ronin+/+, as expected. We propose that the Ronin/
embryos die either during or shortly after implantation, an out-
come that was confirmed by the presence of residual embryonic
tissue in empty decidua from uteri examined after crosses with
Ronin+/ mice (Figure 2A, right).
Next, superovulated immatureRonin+/ females were crossed
withRonin+/males, and 45 blastocyst-stage embryos were iso-
lated. Genotyping of these blastocysts identified nine (20%) as
Ronin/. Crossing Ronin+/ females with WT males produced
the expected ratio of Ronin+/ and Ronin+/+ blastocysts. Upon
gross examination, the Ronin/ blastocysts were indistinguish-
able fromRonin+/+ andRonin+/ blastocysts (Figure 2B, left). The
vast majority (90%) of the ICMs of embryos resulting from addi-
tional Ronin+/ and Ronin+/+ crosses showed outgrowth when
cultured on gelatin-coated culture plates, in contrast to those
from Ronin/ embryos, which either failed to proliferate or, in
one instance, produced only a residual mass (Figure 2B, right).
We propose that Ronin is essential for maintenance and prolifer-
ation of the ICM.
Ronin Knockout ES Cells Are Not Viable
The severe defects in ICM outgrowth in Ronin/ embryos impli-
cated Ronin activity as a critical factor in both the derivation and
propagation of ES cells. Hence, we sought to derive ES cells
from crosses of Ronin+/ mice. Although Ronin+/ ES cell lines
could be readily generated, it was not possible to obtain
Ronin/ lines despite repeated attempts, indicating that Ronin
activity is essential for generating ES cell lines in vitro. Even so,
a knockout phenotype characterized by defects in the ICM
would not necessarily militate against the growth and viability
of cultured ES cells with conditionally deleted alleles. Thus, we
generated Roninflox/flox ES cells, transfected them with a Cre
expression vector, and sorted for Cre recombinase-positive cells
(see Experimental Procedures). Among 110 genotyped sub-
clones, most (90%) were Roninflox/, with none lacking both
alleles. Further testing of the Cre-transfected ES cells revealed
a high rate of a phenotype resembling apoptotic death
(Figure 2C, left), suggesting that Ronin knockout was lethal to
ES cells under standard culture conditions. In contrast, when
Roninflox/flox MEFs derived from E14.5-old embryos were iso-
lated and treated with Cre adenovirus, nearly 100% of the cells
were transduced, resulting in complete knockout of Ronin
(Figure 2C, right). Finally, the Ronin loxP allele was crossed
into the Mx1-Cre background to generate Roninflox/flox—Mx1-
Cre ES cell lines (Whyatt et al., 1993), but the induction of
Mx1-Cre did not lead to deletion of the Ronin allele in any exper-
iment (data not shown). Interestingly, knockdown of Ronin using
siRNA did not result in any overt phenotype in the colony forma-
tion assay (Figures 2D and 2E); however, colony formation
and cell proliferation assays revealed a small but reproducible
decrease in the colony number formed (Figure 2F) and a
significant decrease in the proliferation rate (Figure 2G), in agree-
ment with our knockout data. The most likely interpretation is
that the 50%–80% knockdown efficiency that we achieved
(Figure 2H) is not sufficient to fully unmask the phenotype.
Together, these findings demonstrate a stringent requirement
for Ronin in maintenance of the self-renewal property of ES
cells, as well as in the generation of the ICM during early
embryogenesis.
Forced Expression of Ronin Inhibits Differentiation
of ES cells
Because Ronin possesses several of the critical features of a plu-
ripotency factor, we asked if its ectopic expression in ES cells
would render them independent of LIF for self-renewal. In these
experiments, we established stable ES cell lines expressing
loxP-flanked Ronin under the influence of a constitutive pro-
moter, EF1a. Western blot analyses were used to select several
clones that expressed Ronin in ES cells and had normal
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morphology. To test the effects of Ronin overexpression on ES
cell self-renewal, we plated control ES cells and those ectopi-
cally expressing Ronin (maintained without LIF or with a LIF-
blocking antibody) at clonal densities and analyzed colony for-
mation 4 days later. The vast majority of colonies overexpressing
Ronin appeared morphologically unaffected by LIF removal or
LIF inhibition, in contrast to ES cell controls, which were fully
differentiated (Figure 3A). To quantify this result, we performed
Figure 2. Ronin Is Essential for Normal Embryogenesis and for ES Cell Survival
(A) H&E staining of mouse uterine sections following Ronin+/ crosses. Empty swollen decidua (asterisk, bar = 1 cm, left), WT embryos (middle), and residual
resorbed embryonic tissue (right) at day E6.5 are shown.
(B) Phase contrast images of blastocysts and ICM outgrowth. Ronin/  and Ronin+/ blastocysts (left) and ICM (right) (bar = 30 mm).
(C, left) Immunofluorescent images of Cre-GFP transfected ES cells (arrow indicates typical morphology of apoptotic cells [bar = 20 mm]); (C, right) Immunoflu-
orescent images of MEFs isolated from a Roninflox/flox animal after transfection with GFP adenovirus; insert shows phase contrast image of transduced MEFs.
(D–H) siRNA-mediated knockdown of Ronin in ES cells. R1 cells were transfected with siRNA and the differentiation level assessed 4 days later (AP staining). (D)
Phase contrast images of ES cells transfected with control siRNA, Ronin siRNA, andOct4 siRNA. (E) Quantification of experiment shown in (D). (F) Quantification
of colony number (independent of differentiation level). (G) Proliferation rate of ES cells after treatment with siRNA. (H) Quantification of Ronin expression by
real-time PCR of ES cells 18 hr after treatment with siRNA. All values are means ± SD from triplicate experiments.
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alkaline phosphatase staining 4 days after clonal plating and
determined the percentages of undifferentiated, partially differ-
entiated, and fully differentiated ES cell colonies. As expected,
in the absence of LIF, most of the control ES cell colonies were
either partially (24%) or entirely (60%) differentiated, whereas
two-thirds (65%) of the EF1a-Ronin ES cell colonies remained
undifferentiated under the same conditions (Figures 3B and
3C). Furthermore, there was essentially no background differen-
tiation in EF1a-Ronin ES cell cultures. This remarkable example
of LIF-independent maintenance of pluripotency was further
evaluated at the functional level by culturing ES cells without
LIF for 8 days and subsequently removing the Ronin transgene
with Cre recombinase. All control ES cells differentiated
relatively quickly, to the extent that no cells with typical ES cell
morphology remained in the culture when they were split after
4 days. In sharp contrast, the Ronin-expressing ES cells formed
abundant colonies and could be split after 4 days of culture with-
out LIF. After a total of 8 days in the absence of LIF, clones were
Figure 3. Forced Expression of Ronin
Inhibits Differentiation of ES Cells
(A) Phase contrast images of control ES cells and
EF1a-Ronin ES cells, stably overexpressing
Ronin, after differentiation in monolayer cultures
in the absence or presence of LIF for 4 days. Cells
were split at clonal density under the same condi-
tions. Cells that remained pluripotent after 8 days
of selection were expanded in the presence of
LIF on MEFs and, in a second step, Ronin expres-
sion was silenced by Cre-mediated recombination
to obtain EF1a-DRonin ES cells (bar = 20 mm).
(B) Alkaline phosphatase staining of cells treated
as in (A) at two different magnifications (bar 103 =
80 mm, bar 203 = 40 mm).
(C) Quantification of 3 3 50 colonies from the
experiment described in (B). The values are means
± SD from triplicate experiments.
(D) Chimeric mice generated by injection of
EF1a-DRonin ES cells into blastocysts.
(E) Western blot analysis of Stat3 and Phospho-
Stat3.
expanded and the ectopic Ronin allele
was removed by Cre transfection of ex-
panded clones (EF1a-DRonin). These
cells displayed properties indistinguish-
able from those of WT ES cells, including
monolayer differentiation inmediumwith-
out LIF (Figures 3B and 3C) and the ability
to generate chimeric animals upon injec-
tion into blastocysts, similar to control
cells (Figure 3D). These results indicate
that the absolute differentiation block
was not due to a secondary mutation in
EF1a-Ronin ES cells. They also suggest
that the pluripotency sustained by
ectopic expression of Ronin is reversible.
We also asked whether Ronin can
stimulate phosphorylation of Stat3 in the
absence of LIF. Western blot analysis
(Figure 3E) revealed that in ES cells ectopically expressingRonin,
Stat3 phosphorylation was not sustained after omission of LIF,
indicating that the observed effects of Ronin are independent
of LIF and Stat3 signaling.
To assess the effects of constitutive expression of Ronin on (1)
known pluripotency factors, (2) marker genes for all three germ
layers, and (3) extraembryonic tissues, we isolated RNA from
ES cells on days 1 through 5, after they were plated at low den-
sities in medium without LIF. RT-PCR analysis revealed two
provocative but conflicting results (Figure 4A): (1) virtually all dif-
ferentiation markers were inhibited upon withdrawal of LIF, indi-
cating that forced expression of Ronin inhibits differentiation,
similar to findings with the teratocarcinoma formation assays
(see below), whereas (2) the amount of RNA for some house-
keeping genes, such as b-actin, but not for others, such as
Gapdh, was significantly reduced in repeated experiments
(Figures 4A and S4). In agreement with our observation that
these two genes respond differently to Ronin, we identified the
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Ronin DNA-binding sequence in the b-actin gene but not in the
Gapdh gene. Furthermore, we noticed that Ronin mRNA did
not decrease as much as Oct4 (Figure 4A). This finding suggests
that the repressive function of Ronin is not limited to specific de-
velopmental genes but extends widely over the transcriptome,
a prediction we test in Figure 6.
To determine if knockdown of Oct4 affects the expression of
Ronin, we performed siRNA experiments in whichOct4was rap-
idly downregulated by day 3 while Ronin was upregulated by
comparison with the control. When siRNAs against both genes
were tested, Ronin was downregulated one day earlier than
Oct4 (Figure 4B). These results suggest that Ronin may act inde-
pendently of Oct4 and Nanog to maintain pluripotency, an inter-
pretation supported by the findings of Ivanova et al. (Figure S5;
Ivanova et al., 2006). We wish to point out that Ronin expression
was not significantly affected and even appeared to be slightly
upregulated by knockdown of Oct4/Sox2/Nanog, indicating
that Ronin may not be regulated at the RNA level as stringently
as other pluripotency factors. Functional proof that Ronin-
Figure 4. Ronin Inhibits Differentiation
Independently of Canonical Pluripotency
Factors
(A) Semiquantitative RT-PCR analysis of pluripo-
tency factors and marker genes for all three
germ layers.
(B) siRNA againstOct4 and Roninwas transfected
into ES cells and the expression of their mRNA de-
termined at the indicated time points by real-time
quantitative PCR. Data are reported as means
and SD of triplicate experiments.
(C) Alkaline phosphatase staining of ES cells after
siRNA knockdown of Oct4.
(D) Quantification of result in (C). Bars represent
means and SD of results from triplicate experi-
ments.
(E) Response of ZBHTC4.1 [EF1a] ES cells and
ZBHTC4.1 [EF1a-Ronin] ES cells to doxycyclin.
(F) Quantification of (E). All values are means ± SD
from triplicate experiments.
expressing cells can self-renew indepen-
dently of Oct4 expression came from ex-
periments in whichwe transfected control
and Ronin-expressing cells with siRNA
against Oct4. In contrast to controls, the
reduction of Oct4 expression had no ef-
fect on cell morphology or differentiation
(Figures 4C and 4D). We also stably over-
expressed Ronin in the ZBHTc4.1 ES cell
line, in which Oct4 expression can be
downregulated with use of doxycycline.
As in the preceding Oct4 knockdown ex-
periments, we found that ES cells from
this line continue to self-renew and are
capable of forming colonies after downre-
gulation of Oct4 (Figures 4E, 4F, and S6).
Hence, to maintain pluripotency, Ronin
does not require the LIF/Stat3 pathway
and may not depend on direct interaction with the Oct4/Sox2/
Nanog axis.
Ectopic Expression of Ronin Is Tumorigenic
If Ronin truly acts as an antidifferentiation factor in ES cells, its
overexpression should be associated with strong tumorigenicity.
Thus, to assess teratocarcinoma formation, we injected control
ES cells andEF1a-Ronin ES cell lines into the hindleg quadriceps
muscle of SCID immunocompromised mice. Animals injected
with control ES cells displayed teratocarcinomas of the ex-
pected size by 17 days, while those injected with EF1a-Ronin
had substantially larger tumors (2.8 cm versus 1.8) in two inde-
pendent experiments, suggesting that increased Ronin activity
triggers expansion of the stem cell pool, leading to more robust
teratocarcinoma formation prior to differentiation (Figure 5A).
Histologic examination of the teratocarcinomas derived from
both control ES and Ronin-expressing EF1a-Ronin ES cells re-
vealed differentiation into all three germ layers in both contexts
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undifferentiated cell clusters in the EF1a-Ronin tumors that
resembled embryonic carcinoma cells (Figure 5B, top left). This
impression was supported by immunostaining results indicating
Oct4-positive cell clusters among the EF1a-Ronin ES cells but
not the control ES cell line (Figure 5A, bottom panels). Thus,
the enhanced tumorigenicity of ES cells constitutively express-
ing Ronin appears to stem from the antidifferentiation effects
of this factor, supporting its candidacy as a key regulator of
the pluripotent state.
Ronin Is a Transcriptional Repressor That Acts through
aMultimeric Protein Protein Complex Containing HCF-1
How does Ronin maintain the pluripotency of ES cells? The most
plausible mechanism, based on Ronin’s antidifferentiation ef-
fects and the epigenetic silencing activity of other THAP domain
proteins (Roussigne et al., 2003a, 2003b; Macfarlan et al., 2005),
is transcriptional repression of multiple genes that are either di-
rectly or indirectly involved in differentiation. To test this hypoth-
esis, we performed gene expression profiling of control ES cells
versus ES cells transiently transfected with a Ronin-overex-
pressing construct. This comparison (Figure 6A) showed a strik-
ing repression of the transcriptome of Ronin-transfected cells,
reflecting either a large decrease in RNA stability or in the synthe-
sis rate of new RNA. To distinguish between these possibilities,
we generated a Ronin-inducible cell line by inserting Ronin-
encoding cDNA, under the control of a tetracycline-inducible
promoter, upstream of the Hprt locus in A172loxP ES cells and
compared the kinetics of RNA transcription in control versus
Ronin-expressing cells stained with a bromodeoxyuridine anti-
body against 5-fluorouracil (5-FU). There was a clear and rapid
loss of newly synthesized RNA in cells that overexpressed Ronin
(Figure 6B), indicating broad transcriptional repression. This out-
come was confirmed by the results of a 3H-uridine pulse-chase
incorporation assay (Figure 6C). Finally, western blot analysis
to detect histone H3 dimethylation at lysine 9 (H3K9me2), a reli-
able marker of chromatin-mediated gene repression, showed
Figure 5. Ectopic Expression of Ronin Is
Tumorigenic
(A) Immunohistochemical staining of Oct4 in
teratocarcinoma sections. Tumors formed by
EF1a-Ronin ES cells (top) and those formed by
R1 control cells (bottom); insert: 403 magnifica-
tion of typical Oct4-positive cell cluster in EF1a-
Ronin-derived tumor; bar (top) = 0.5 cm, bar
(bottom) = 0.1 mm.
(B) H&E staining of EF1a-Ronin teratocarcinoma
sections; white arrows indicate clusters of un-
differentiated cells, bar = 50 mm.
a large and rapid increase in the methyla-
tion of this protein over time in our Ronin-
inducible cell line (Figure 6D). We further
tested the ability of Ronin to bind to its
target sequence in undifferentiated ES
cells. Evidence for direct repression of
genes involved in differentiation is pro-
vided in Figure 6E, which shows that Ronin binds to the 3x se-
quence present in the promoter regions of GATA4 and GATA6.
Both of these genes show H3K9 methylation in the same region,
and neither gene is transcribed in ES cells. After induction of dif-
ferentiation, GATA4 and GATA6 are no longer bound by Ronin,
and their H3K9 methylation is diminished. Interestingly, we
also identified a putative DNA-binding sequence for Ronin in
the promoter region of Oct4, and indeed Ronin did bind to this
region, but only in differentiated ES cells; Nanog did not possess
a similar binding sequence and was not bound by Ronin
(Figure 6E). These observations strengthen the argument that
Ronin suppresses gene expression in ES cells by directly binding
to key genetic loci and recruiting epigenetic modifiers.
To pursue the idea that Ronin exerts its antidifferentiation
effects through epigenetic silencing of gene expression, we
devised an immunoprecipitation strategy to identify protein
complexes associated with FLAG-tagged Ronin in ES cells.
Putative interaction partners were separated by SDS gel electro-
phoresis and the protein bands subjected to protein tandem
mass spectrometry analysis. Of 80 candidate proteins, 32 were
selected for further evaluation by a directional yeast two-hybrid
system. In this approach, full-length Ronin as well as two trun-
cated forms carrying the N terminus (Ronin-N) or the C terminus
(Ronin-C) were tested for their ability to bind directly to selected
putative interaction partners (Figure 7A). The only direct interac-
tion that was identified was between Ronin-C and HCF-1. Retro-
spective analysis of the Ronin sequence (not shown) revealed
a previously described HCF-1 interaction motif (Freiman and
Herr, 1997) at the C terminus of themolecule, making this protein
a likely direct target of Ronin. To confirm that HCF-1 is indeed
a functional target for Ronin, we performed HCF-1 knockdown
experiments in ES cells ectopically expressing Ronin. Knock-
down of this gene in bothWT and Ronin-overexpressing ES cells
generated the same phenotype, suggesting that Ronin expres-
sion cannot compensate for loss of HCF-1 and hence that Ronin
and HCF-1 are functionally related with respect to self-renewal
(Figure 7B).Cell 133, 1162–1174, June 27, 2008 ª2008 Elsevier Inc. 1169
Wysocka and coworkers (Wysocka et al., 2003) isolated amul-
timeric HCF-1-containing protein complex from HeLa cells by
taking advantage of the glycoprotein properties of HCF-1.
Hence, we applied a similar strategy to purify a Ronin protein
complex from EF1a-Ronin ES cells. Comparison with the elution
peaks of protein standards of known sizes, detected by Coo-
massie blue staining, suggested that Ronin functions within
a very large (>2 MDa) protein complex (Figure 7C). To identify
some of the components of this complex, we selected the
same set of proteins used for the yeast two-hybrid evaluation
and modified them for the use in cotransformation assays.
Thus, 293 cells were cotransfected with GST-tagged variants
of Ronin, Ronin-C or Ronin-N, and with Myc-tagged variants of
the putative interaction partners. Using this strategy, we con-
firmed the binding of Ronin to HCF-1 via the C terminus. Other
confirmed protein interaction partners (Figure 7D) were Ronin
itself (via homodimerization through the C terminus); THAP7, an-
other THAP domain protein (via heterodimerization through the
N terminus); and Sin3A (C terminus) and HDAC3 (N terminus)—
all factors associated with transcriptional repression or histone
modifications. We therefore suggest that Ronin acts through
a large HCF-1-containing protein complex that can modulate
Figure 6. Ronin Acts as a Transcriptional
Repressor and Epigenetic Modulator
(A, left) Box plots showing results of microarray
analysis of control ES cells and ES cells 24 hr after
transfection with pEF1a-hRonin-Flag. Each box
represents median and 75th and 25th percentile
values.
(B) Confocal images of 5-fluorouridine (5-FU)
staining of newly transcribed RNA after induction
of Ronin expression in a Ronin-inducible cell line
(bar = 10 mm).
(C) Quantification of 3H-uridine incorporation into
newly transcribed RNA of control A172loxP cells
and A172LP-Ronin-Flag cells after induction with
1 mg/ml doxycycline. Bars represent means and
SD of triplicate experiments.
(D) Western blot analysis of H3K9me2 methyla-
tion.
(E) Chromatin immunoprecipitation and PCR of
genomic regions upstream of Gata4, Gata6, Oct4,
and Nanog.
or repress gene expression over broad
regions of the transcriptome.
DISCUSSION
Our findings promote the candidacy of
Ronin as a pluripotency factor with func-
tions that appear to differ from those of
canonical pluripotency factors. Like
Oct4 and Sox2, but not Nanog, Ronin
was highly expressed in the ooplasm of
mature oocytes (Okamoto et al., 1990;
Rosner et al., 1990; Scholer et al., 1990;
Avilion et al., 2003; Chambers et al.,
2003), which may indicate its involvement in oocyte maturation.
After fertilization, Ronin was found throughout the zygote, sug-
gesting that it is essential for establishing the zygotic stage of
the embryo. Indeed, the Ronin gene begins to be expressed at
a time in embryonic development when zygotic gene transcrip-
tion is generally initiated. Ronin’s expression pattern indicates
differential requirements during early embryogenesis and in ES
cells, a notion supported by the apparent ability of the Ronin pro-
tein to shuttle between the nucleus and the cytoplasm. Whether
the nuclear and cytoplasmic proteins have different functions
remains an open question; nonetheless, our data strongly
suggest that Ronin is tightly regulated at the protein level.
Ronin was also expressed in specific areas of the adult brain,
suggesting that it fills specific roles in these regions that may be
related to specialized requirements for epigenetic and transcrip-
tional regulation, as in ES cells. Otherwise, the Ronin expression
level in adult animals was very low or nonexistent, although we
cannot rule out the possibility that Ronin may be highly ex-
pressed in rare populations of stem or progenitor cells with
exceptional needs for plasticity, analogous to expression of the
newly recognized Zfx gene in both ES and hematopoietic stem
cells (Galan-Caridad et al., 2007). Finally, Ronin transcription1170 Cell 133, 1162–1174, June 27, 2008 ª2008 Elsevier Inc.
was turned off after induction of ES cell differentiation, but the
disappearance of Ronin mRNA was delayed by comparison to
the mRNA of other factors, such as DPPA4 (Sperger et al.,
2003), suggesting that Ronin may be required not only during
the very early stages of embryonic development, but also during
the differentiation stage. The results of our Ronin lacZ reporter
assay argue strongly for selective expression of Ronin in a very
limited number of cell types. If confirmed, this expression pattern
might explain how Ronin has escaped detection by expression
profiling of genes important for ES cell function and why it is rep-
resented by only marginal levels of expression in available data-
bases (e.g., NIH SAGE).
The lethal defect in Ronin knockout mouse embryos likely re-
sides within the ICM itself, as predicted by the striking similarities
with the Oct4 and Nanog knockout phenotypes (Nichols et al.,
1998;Mitsui et al., 2003) and the finding that Ronin is an essential
protein in ES cells. Nonetheless, we cannot rule out a defect in
Figure 7. Ronin Binds Directly to HCF-1 and
Is Associated with a Very Large Protein
Complex
(A) Directional yeast two-hybrid approach to
detect direct interaction of Ronin, Ronin-C, and
Ronin-Nwith candidate interacting proteins identi-
fied by mass spectometry. Direct interaction of
Ronin-C with HCF-1 is represented by growth of
cotransfected MAV103 yeast on 50 mM 3AT-con-
taining plates (AD = activation domain, DB = DNA-
binding domain).
(B) Downregulation of HCF-1 by siRNA in control
ES cells and Ronin ectopically expressing ES
cells.
(C) Anti-Ronin-Flag western blot of glycerol gradi-
ent fractions of EF1a-Ronin ES cell nuclear ex-
tracts purified with wheat germ agglutinin beads.
Ronin is present in the first 5 fractions and in frac-
tions 20 to 23with a peak in fraction 20. The elution
peaks of protein standards with known sizes are
compared (top).
(D) Western blot of Myc-tagged proteins after GST
immunoprecipitation. Ronin interacts via its C
terminus with itself, HCF-1, and Sin3A and via its
N-terminus with HDAC3 and Thap7. R, Ronin; C,
Ronin C terminus; N, Ronin N terminus; D, empty
destination vector.
(E) Proposed model for the mechanism of Ronin
function.
extraembryonic tissues required for the
formation of the ICM. It is noteworthy
that the expression pattern of Ronin
does not necessarily contradict the lethal
phenotype we observed in Ronin knock-
out embryos. Indeed, Ronin protein is
present in the ICM (Figure 1G) and would
be expected to function at that stage of
development, so that its loss might well
be lethal to the blastocyst. Whatever the
explanation, our analysis of the Ronin
expression pattern and the finding that
Ronin knockout produces no phenotype in MEFs clearly indicate
that the protein performs very specific functions in ES cells.
Although ES cells do not require Sox2 and Nanog for mainte-
nance of the pluripotent state, at least in some contexts (Cham-
bers et al., 2007; Masui et al., 2007), they do show an absolute
dependency on Oct4, whose function cannot be replaced by
other pluripotency factors tested to date (Ivanova et al., 2006).
Hence, a major finding of our study is the ability of Ronin to over-
ride (at least partially) the requirement for Oct4 in the mainte-
nance of pluripotency. To exclude the possibility that a small
subfraction of cells might still be capable of undergoing self-
renewal even in the absence of Ronin, we conditionally removed
the endogenous Ronin allele in ES cells and observed that Ronin
knockout seems to lead to rapid cell death. This result could
reflect the inability of the tissue culture medium to support prop-
agation of the particular cell type generated by Ronin-deficient
ES cells, but this possibility seems unlikely because our mediumCell 133, 1162–1174, June 27, 2008 ª2008 Elsevier Inc. 1171
contains serum and supports all major lineages derived from ES
cells. The most plausible explanation is that loss of Ronin
activates large blocks of normally repressed genes, whose un-
scheduled expression leads to programmed cell death. How-
ever, we cannot rule out a direct effect of Ronin deficiency on
the cell’s apoptotic machinery. Moreover,Roninwas able to sus-
tain the undifferentiated state of cultured ES cells even in the
absence of LIF, an essential self-renewal factor that operates
through the Jak-Stat pathway (Smith, 2001). A lack of complete
dependence of Ronin function on canonical pathways was fur-
ther indicated by its persistent expression upon knockdown of
Oct4, Sox2, and Nanog. Taken together, these observations
suggest a need to reconsider the prevailing Oct4/Sox2/Nanog-
centric view of ES cell pluripotency.
We think it is important that in the teratocarcinoma model,
Ronin acts as a tumor-promoting factor. Given that Ronin is
expressed in some cells in the adult animal, it may possess a
tumor-promoting function as well as the ability to regulate pluri-
potency. Indeed, the human RONIN gene is located on chromo-
some 16q22.1, a locus that has been associated with several
forms of cancer, including leukemias, squamous cell carcino-
mas, and breast and prostate cancers, and RONIN was found
to be overexpressed in tumors (Frengen et al., 2000; Yan et al.,
2007).
A defining feature of Ronin is its THAP domain (Roussigne
et al., 2003a, 2003b), whose zinc-finger DNA-binding motif is
shared with a large family of cellular factors (more than 100 dis-
tinct members) in the animal kingdom. It has been proposed that
THAP-containing proteins act at the level of chromatin regulation
because of their frequent interaction with chromatin- modifying
proteins (Macfarlan et al., 2005, 2006). The DNA sequence rec-
ognized by Ronin is unusually long, in agreement with data on
Thap1, another THAP domain-containing protein that is respon-
sible for regulating pRB-E2F target genes (Bessiere et al., 2007;
Cayrol et al., 2007). However, the DNA sequence recognized by
Thap1 differs from that recognized by Ronin, suggesting that
each THAP domain may recognize a different DNA sequence,
an idea supported by recent elucidation of structures within
the THAP domain of Thap1 (Bessiere et al., 2007). Among the
THAP family members, proteins that interact with chromatin-
modifying elements, Thap7 and HIM-17 are perhaps the best
characterized. Thap7 associates with both histone tails and
HDACs (Macfarlan et al., 2005, 2006), while HIM-17 is involved
in recruitment of the methyltransferase activity to histone H3 at
lysine 9 (Reddy and Villeneuve, 2004; Bessler et al., 2007).
We hypothesize that Ronin suppresses the activity of multiple
genes by binding directly to DNA and then recruiting HCF-1 and
thus chromatin-modifying proteins. The association of HCF-1
with both activating and repressive epigenetic modifications rai-
ses the intriguing possibility that Ronin interaction with HCF-1
could introduce conflicting chromatin marks (so-called bivalent
domains) at specific sites. An alternative hypothesis is that Ronin
may affect RNA stability.
Ourmodel (Figure 7E) predicts that Ronin acts broadly on tran-
scription in pluripotent cells, in contrast to the canonical pluripo-
tency factors (Oct4, Sox2, and Nanog), which modulate very
specific particular genes that are required for either pluripotency
or differentiation events. Thus, the major difference between1172 Cell 133, 1162–1174, June 27, 2008 ª2008 Elsevier Inc.Ronin and other pluripotency factors may lie in the scope of its
action. If so, Ronin could be functionally compared in the broad-
est sense with the C. elegans PIE-1 protein, which globally
represses transcription in germ cells as an integral step in its nor-
mal function (Blackwell, 2004). This model does not exclude the
possibility that Ronin and the canonical pluripotency factors
might act in parallel, perhaps on the same genes. Indeed, the
DNA sequence bound by Ronin (3x) is upstream of many key
development genes known to be targets of established pluripo-
tency factors (e.g., GATA4 and GATA6), and Ronin seems to
bind to genomic regions associated with epigenetic silencing
marks. This hypothesis is further strengthened by the fact that
depending on the differentiation status of ES cells, Ronin can
bind to the Oct4 promoter. Identification of other key genes rec-
ognized by Ronin will help to elucidate the specific functions of
this factor.
Our discovery and analysis of Ronin has several implications
for the mechanisms that underlie pluripotency. Despite numer-
ous investigations of factors that participate in the control of plu-
ripotency, this state is still defined purely in functional terms.
Thus, whether a particular cell is pluripotent (differentiation to
all cells in the body), capable of contributing to the germline
only (germline transmission), multipotent (differentiation to
somebut not all cell types), or unipotent (differentiation to a single
cell type only) cannot be addressed in molecular terms with any
degree of certainty. Our findings identifying Ronin as a novel type
of pluripotency factor suggest a new tier of control in addition to
the transcriptional circuit now believed to regulate ES cell pluri-
potency and contribute importantly to delineation of the role of
epigenetic factors in this regulation.
EXPERIMENTAL PROCEDURES
ES Cell Culture
MEFs andHEK293 cells were cultured in Dulbecco’sModified Eagle’sMedium
(DMEM; GIBCO) supplemented with 10% fetal bovine serum (FBS; GIBCO),
L-Glutamine (GIBCO), 100 nM nonessential amino acids (GIBCO), and 100 mM
beta-mercaptoethanol (Fluka). ES cells were cocultured with MEFs (or in
0.1% gelatin-coated dishes) in Knock-Out DMEM (GIBCO) containing the
same supplements as MEF medium, plus 1000 U/ml LIF (Chemicon).
Targeted Deletion of the Mouse Ronin Gene
A targeting vector specific for the mouse Ronin allele was created in a four-
step cloning procedure (see Supplemental Experimental Procedures) using
the pfrt-loxP plasmid as a backbone (a gift from Dr. James Martin, Texas
A&M Institute of Biotechnology).
Generation of EF1a-Ronin ES Cells
EF1a-Ronin mouse ES cells, in which constitutive, ectopic expression of
FLAG-tagged human Ronin could be eliminated by a Cre recombination event,
were generated by introducing FLAG tag and loxP sites and the desired restric-
tion sites using PCR, as described in the Supplemental Experimental Proce-
dures. The resulting vector was electroporated into R1 ES cells, and individual
ES cell colonies were screened for Ronin expression.
siRNA Knockdown Experiments
To induce differentiation by knocking down oct3/4, R1 cells, or EF1a-Ronin ES
cells, cells were plated and transfected with Smart Pool siRNA oct3/4 using
Lipofectamine2000. GFP duplex siRNA (Dharmacon) served as a negative
control in a parallel experiment. Cell morphology was assessed by alkaline
phosphatase staining after 3 days.
5-Fluorouridine Staining of Newly Transcribed RNA
A172loxP or A172LP-Ronin-FLAG cells were plated on an MEF feeder layer in
2-chamber slides. After 8 hr, Ronin expression was induced with doxycycline,
and 12 hr later nascent RNA was labeled by incubation with 100 mM 5-fluo-
rouridine (5-FU) for 1 hr. 5-FU was detected with an anti-BrdU primary anti-
body. Ronin was detected with the Ronin antiserum, G4275. Cells were
mounted and examined by fluorescence microscopy.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and six
figures and can be found with this article online at http://www.cell.com/cgi/
content/full/133/7/1162/DC1/.
ACKNOWLEDGMENTS
We thank R.R. Behringer, M.K. Brenner, A. Antebi, R. Stewart, andM.A. Good-
ell for critical reading of the manuscript and A. Crane for some technical assis-
tance. We thank Dr. Hitoshi Niwa for providing us with ZBHTc4.1 ES cells. This
work was supported by the Lance Armstrong Foundation (T.P.Z.), the Gillson
Longenbaugh Foundation (T.P.Z.), the Tilker Medical Research Foundatiom
(T.P.Z.), the Diana Helis Henry Medical Research Foundation (T.P.Z.), the Huf-
fington Foundation (T.P.Z.), the NIH (grants R01 EB005173-01, P20 EB007076,
and P01 GM81627), the PhRMA Foundation (J.S.K.), and NIH training grant
5T32DK060445 (J.S.K.).
Received: February 9, 2008
Revised: April 24, 2008
Accepted: May 22, 2008
Published: June 26, 2008
REFERENCES
Avilion, A.A., Nicolis, S.K., Pevny, L.H., Perez, L., Vivian, N., and Lovell-Badge,
R. (2003). Multipotent cell lineages in early mouse development depend on
SOX2 function. Genes Dev. 17, 126–140.
Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff, J., Fry,
B., Meissner, A., Wernig, M., Plath, K., et al. (2006). A bivalent chromatin struc-
ture marks key developmental genes in embryonic stem cells. Cell 125, 315–
326.
Bessiere, D., Lacroix, C., Campagne, S., Ecochard, V., Guillet, V., Mourey, L.,
Lopez, F., Czaplicki, J., Demange, P., Milon, A., et al. (2007). Structure-
function analysis of the thap-zinc finger of thap1, a large C2CH DNA-binding
module linked to RB/E2F pathways. J. Biol. Chem. 283, 4352–4363.
Bessler, J.B., Reddy, K.C., Hayashi, M., Hodgkin, J., and Villeneuve, A.M.
(2007). A role for Caenorhabditis elegans chromatin-associated protein
HIM-17 in the proliferation vs. meiotic entry decision. Genetics 175, 2029–
2037.
Blackwell, T.K. (2004). Germ cells: finding programs of mass repression. Curr.
Biol. 14, R229–R230.
Bouvet, P. (2000). Determination of nucleic acid recognition sequence by SE-
LEX. In Methods in Molecular Biology, DNA-Protein Interaction: Principles and
Protocols, 148, T. Moss, ed. (Totowa, NJ: Humana Press Inc.), pp. 603–610.
Boyer, L.A., Lee, T.I., Cole, M.F., Johnstone, S.E., Levine, S.S., Zucker, J.P.,
Guenther, M.G., Kumar, R.M., Murray, H.L., Jenner, R.G., et al. (2005). Core
transcriptional regulatory circuitry in human embryonic stem cells. Cell 122,
947–956.
Boyer, L.A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L.A., Lee, T.I.,
Levine, S.S., Wernig, M., Tajonar, A., Ray, M.K., et al. (2006). Polycomb
complexes repress developmental regulators in murine embryonic stem cells.
Nature 441, 349–353.
Cayrol, C., Lacroix, C., Mathe, C., Ecochard, V., Ceribelli, M., Loreau, E., Lazar,
V., Dessen, P., Mantovani, R., Aguilar, L., and Girard, J.P. (2007). The
THAP-zinc finger protein THAP1 regulates endothelial cell proliferation
through modulation of pRB/E2F cell-cycle target genes. Blood 109, 584–594.Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., and
Smith, A. (2003). Functional expression cloning of nanog, a pluripotency
sustaining factor in embryonic stem cells. Cell 113, 643–655.
Chambers, I., Silva, J., Colby, D., Nichols, J., Nijmeijer, B., Robertson, M.,
Vrana, J., Jones, K., Grotewold, L., and Smith, A. (2007). Nanog safeguards
pluripotency and mediates germline development. Nature 450, 1230–1234.
Evans, M.J., and Kaufman, M.H. (1981). Establishment in culture of pluripoten-
tial cells from mouse embryos. Nature 292, 154–156.
Fujita, J., Crane, A.M., Souza, M.K., Dejosez, M., Kyba, M., Flavell, R.A.,
Thomson, J.A., and Zwaka, T.P. (2008). Caspase activity mediates the differ-
entiation of embryonic stem cells. Cell Stem Cell 2, 595–601.
Freiman, R.N., and Herr, W. (1997). Viral mimicry: Common mode of associa-
tion with HCF by VP16 and the cellular protein LZIP. Genes Dev. 11, 3122–
3127.
Frengen, E., Rocca-Serra, P., Shaposhnikov, S., Taine, L., Thorsen, J., Bepol-
din, C., Krekling, M., Lafon, D., Aas, K.K., El Moneim, A.A., et al. (2000). High-
resolution integrated map encompassing the breast cancer loss of heterozy-
gosity region on human chromosome 16q22.1. Genomics 70, 273–285.
Galan-Caridad, J.M., Harel, S., Arenzana, T.L., Hou, Z.E., Doetsch, F.K., Mirny,
L.A., and Reizis, B. (2007). Zfx controls the self-renewal of embryonic and
hematopoietic stem cells. Cell 129, 345–357.
Houlard, M., Berlivet, S., Probst, A.V., Quivy, J.P., Hery, P., Almouzni, G., and
Gerard, M. (2006). CAF-1 is essential for heterochromatin organization in plu-
ripotent embryonic cells. PLoS Genet 2, e181. 10.1371/journal.pgen.0020181.
Ivanova, N., Dobrin, R., Lu, R., Kotenko, I., Levorse, J., DeCoste, C., Schafer,
X., Lun, Y., and Lemischka, I.R. (2006). Dissecting self-renewal in stem cells
with RNA interference. Nature 442, 533–538.
Klochendler-Yeivin, A., Fiette, L., Barra, J., Muchardt, C., Babinet, C., and Ya-
niv, M. (2000). The murine SNF5/INI1 chromatin remodeling factor is essential
for embryonic development and tumor suppression. EMBO Rep. 1, 500–506.
Lee, T.I., Jenner, R.G., Boyer, L.A., Guenther, M.G., Levine, S.S., Kumar, R.M.,
Chevalier, B., Johnstone, S.E., Cole, M.F., Isono, K., et al. (2006). Control of
developmental regulators by Polycomb in human embryonic stem cells. Cell
125, 301–313.
Macfarlan, T., Kutney, S., Altman, B., Montross, R., Yu, J., and Chakravarti, D.
(2005). Human THAP7 is a chromatin-associated, histone tail-binding protein
that represses transcription via recruitment of HDAC3 and nuclear hormone
receptor corepressor. J. Biol. Chem. 280, 7346–7358.
Macfarlan, T., Parker, J.B., Nagata, K., and Chakravarti, D. (2006). Thanatos-
associated protein 7 associates with template activating factor-Ibeta and in-
hibits histone acetylation to repress transcription. Mol. Endocrinol. 20, 335–
347.
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld,
M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007). Directly reprog-
rammed fibroblasts show global epigenetic remodeling and widespeard
tissue contribution. Cell Stem Cell 1, 55–70.
Martin, G.R. (1981). Isolation of a pluripotent cell line from early mouse em-
bryos cultured in medium conditioned by teratocarcinoma stem cells. Proc.
Natl. Acad. Sci. USA 78, 7634–7638.
Masui, S., Nakatake, Y., Toyooka, Y., Shimosato, D., Yagi, R., Takahashi, K.,
Okochi, H., Okuda, A., Matoba, R., Sharov, A.A., et al. (2007). Pluripotency
governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic
stem cells. Nat. Cell Biol. 9, 625–635.
Matsui, Y., Zsebo, K., and Hogan, B.L. (1992). Derivation of pluripotential
embryonic stem cells from murine primordial germ cells in culture. Cell 70,
841–847.
Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K.,
Maruyama, M., Maeda, M., and Yamanaka, S. (2003). The homeoprotein
Nanog is required for maintenance of pluripotency in mouse epiblast and ES
cells. Cell 113, 631–642.
Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D.,
Chambers, I., Scholer, H., and Smith, A. (1998). Formation of pluripotentCell 133, 1162–1174, June 27, 2008 ª2008 Elsevier Inc. 1173
stem cells in the mammalian embryo depends on the POU transcription factor
Oct4. Cell 95, 379–391.
Niwa, H., Miyazaki, J., and Smith, A.G. (2000). Quantitative expression of Oct-
3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat.
Genet. 24, 372–376.
Okamoto, K., Okazawa, H., Okuda, A., Sakai, M., Muramatsu, M., and Ham-
ada, H. (1990). A novel octamer binding transcription factor is differentially
expressed in mouse embryonic cells. Cell 60, 461–472.
Okita, K., Ichisaka, T., and Yamanaka, S. (2007). Generation of germline-com-
petent induced pluripotent stem cells. Nature 448, 313–317.
Pedersen, R.A. (1986). Potency, lineage and allocation in preimplantation
mouse embryos. In Experimental Approaches to Mammalian Embryonic
Development, J. Rossant and R.A. Pedersen, eds. (New York: Cambridge
University Press), pp. 3–33.
Reddy, K.C., and Villeneuve, A.M. (2004). C. elegans HIM-17 links chromatin
modification and competence for initiation of meiotic recombination. Cell
118, 439–452.
Rosner, M.H., Vigano,M.A., Ozato, K., Timmons, P.M., Poirier, F., Rigby, P.W.,
and Staudt, L.M. (1990). A POU-domain transcription factor in early stem cells
and germ cells of the mammalian embryo. Nature 345, 686–692.
Roussigne, M., Cayrol, C., Clouaire, T., Amalric, F., and Girard, J.P. (2003a).
THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-
response-4 (Par-4) to PML nuclear bodies. Oncogene 22, 2432–2442.
Roussigne, M., Kossida, S., Lavigne, A.C., Clouaire, T., Ecochard, V., Glories,
A., Amalric, F., and Girard, J.P. (2003b). The THAP domain: a novel protein
motif with similarity to the DNA-binding domain of P element transposase.
Trends Biochem. Sci. 28, 66–69.
Scholer, H.R., Ruppert, S., Suzuki, N., Chowdhury, K., and Gruss, P. (1990).
New type of POU domain in germ line-specific protein Oct-4. Nature 344,
435–439.
Smith, A.G. (2001). Embryo-derived stem cells: of mice and men. Annu. Rev.
Cell Dev. Biol. 17, 435–462.1174 Cell 133, 1162–1174, June 27, 2008 ª2008 Elsevier Inc.Sperger, J.M., Chen, X., Draper, J.S., Antosiewicz, J.E., Chon, C.H., Jones,
S.B., Brooks, J.D., Andrews, P.W., Brown, P., and Thomson, J.A. (2003).
Gene expression patterns in human embryonic stem cells and human pluripo-
tent germ cell tumors. Proc. Natl. Acad. Sci. USA 100, 13350–13355.
Takahashi, K., and Yamanaka, S. (2006). Induction of pluripotent stem cells
from mouse embryonic and adult fibroblast cultures by defined factors. Cell
126, 663–676.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K.,
and Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human
fibroblasts by defined factors. Cell 131, 861–872.
Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J.,
Marshall, V.S., and Jones, J.M. (1998). Embryonic stem cell lines derived from
human blastocysts. Science 282, 1145–1147.
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger,
K., Bernstein, B.E., and Jaenisch, R. (2007). In vitro reprogramming of fibro-
blasts into a pluripotent ES-cell-like state. Nature 448, 318–324.
Whyatt, L.M., Duwel, A., Smith, A.G., and Rathjen, P.D. (1993). The respon-
siveness of embryonic stem cells to alpha and beta interferon provides the
basis of an inducible expression system for analysis of developmental control
genes. Mol. Cell. Biol. 13, 7971–7976.
Wysocka, J., Myers, M.P., Laherty, C.D., Eisenman, R.N., and Herr, W. (2003).
Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3–K4
methyltransferase are tethered together selectively by the cell-proliferation
factor HCF-1. Genes Dev. 17, 896–911.
Yan, B., Yang, X., Lee, T.L., Friedman, J., Tang, J., VanWaes, C., and Chen, Z.
(2007). Genome-wide identification of novel expression signatures reveal dis-
tinct patterns and prevalence of binding motifs for p53, nuclear factor-kappaB
and other signal transcription factors in head and neck squamous cell carci-
noma. Genome Biol. 8, R78.
Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L.,
Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., et al. (2007). Induced
pluripotent stem cell lines derived from human somatic cells. Science 318,
1917–1920.
